Guardant Health, Inc. (GH) has 44 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 11 sales totalling $53.9M. Most recent filing: Sept. 17, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 17, 2026 filed Sept. 15, 2026 | Chudova Darya Chief Technology Officer | −$1,377,364 | 7,738 | −10% | No | |
|
|
||||||
| Sept. 17, 2026 filed Sept. 16, 2026 | Krognes Steve E. Director | −$1,172,886 | 6,674 | −46% | No | |
|
|
||||||
| Sept. 17, 2026 filed Sept. 16, 2026 | Azar Alex M II Director | −$144,550 | 826 | −50% | Yes | |
|
|
||||||
| Sept. 17, 2026 filed Sept. 15, 2026 | Tariq Musa Director | — | +133 | +1% | Yes | |
|
|
||||||
| Sept. 14, 2026 filed Sept. 11, 2026 | Kalia Kumud Chief Information Officer | −$632,193 | 4,000 | −9% | No | |
|
|
||||||
Showing the 5 most recent of 44 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free